Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
5%
downside
7 price targets
|
0
%
|
|
|
|
5%
downside
10 price targets
|
0
%
|
|
|
|
5%
downside
5 price targets
|
0
%
|
|
|
1679
Target
TGT
$45.1B
|
5%
downside
16 price targets
|
0
%
|
|
|
5%
downside
4 price targets
|
0
%
|
|
|
|
6%
downside
4 price targets
|
0
%
|
|
|
|
6%
downside
8 price targets
|
0
%
|
|
|
|
6%
downside
11 price targets
|
0
%
|
|
|
|
6%
downside
7 price targets
|
0
%
|
|
|
|
6%
downside
10 price targets
|
0
%
|
|
|
1686
PTC Therapeutics
PTCT
$6.31B
|
6%
downside
7 price targets
|
0
%
|
|
|
6%
downside
7 price targets
|
0
%
|
|
|
|
6%
downside
4 price targets
|
0
%
|
|
|
|
6%
downside
5 price targets
|
0
%
|
|
|
|
6%
downside
5 price targets
|
0
%
|
|
|
|
6%
downside
3 price targets
|
0
%
|
|
|
|
7%
downside
3 price targets
|
0
%
|
|
|
|
7%
downside
4 price targets
|
0
%
|
|
|
|
7%
downside
18 price targets
|
0
%
|
|
|
|
8%
downside
4 price targets
|
0
%
|
|
|
|
8%
downside
6 price targets
|
0
%
|
|
|
|
8%
downside
6 price targets
|
0
%
|
|
|
|
8%
downside
7 price targets
|
0
%
|
|
|
|
8%
downside
6 price targets
|
0
%
|
|
|
|
8%
downside
8 price targets
|
0
%
|
|